Actively Recruiting
The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection
Led by Seoul National University Bundang Hospital · Updated on 2026-04-24
600
Participants Needed
1
Research Sites
695 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To compare the eradication success rate between 10-days sequential therapy and 7-days tailored therapy based on H. pylori culture and antimicrobial susceptibility testing.
CONDITIONS
Official Title
The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with confirmed H. pylori infection by positive rapid urease test, histologic evidence by Giemsa staining, or positive urea breath test
- Male and female Korean adults aged 18 years or older
You will not qualify if you...
- Prior H. pylori eradication therapy
- Previous H. pylori eradication failure due to poor compliance
- Use of antibiotics or bismuth salts within 4 weeks or proton pump inhibitors within 2 weeks
- Advanced gastric cancer or other malignancies
- Abnormal liver function or liver cirrhosis
- Abnormal kidney function or chronic kidney disease
- Other severe concurrent diseases
- Previous allergic reactions to study drugs
- Pregnant or lactating women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 463-707
Actively Recruiting
Research Team
N
Nayoung Kim, M.D., Ph. D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here